4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-035430
Chief Executive Officer sold 24,338 shares at $24.21 ($589,223)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2023-10-25 | Sale 10b5-1 | −24,338 | $24.21 | $589,223 | 3,737,000 | D |
| Open-market sales · 24,338 sh · avg $24.21 · $589,223 | |||||||
Loading xslF345X05/wk-form4_1698445412.xml…